lunes, 10 de diciembre de 2018

'Rebate walls' for drugs should be dismantled by the FTC - STAT

'Rebate walls' for drugs should be dismantled by the FTC - STAT

First Opinion



Drug ‘rebate walls’ should be dismantled by the FTC’s antitrust arm

By DAVID BALTO


ADOBE
Rebate walls have inflated the price of drugs and stifled the ability of drug companies to compete on costs. The FTC should dismantle these walls.

No hay comentarios: